» Authors » Chun-Kai Pan

Chun-Kai Pan

Explore the profile of Chun-Kai Pan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 41
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen J, Pan C, Lin L, Huang Y, Huang T, Yang S, et al.
Cancer Immunol Immunother . 2024 Nov; 74(1):8. PMID: 39487895
We investigated the combined effects of ataxia telangiectasia and Rad3-related (ATR) inhibition, ablative radiotherapy, and immune checkpoint inhibitor (ICI) therapy against lung cancer. ATR inhibitor was administered combined with ablative...
2.
Chen J, Yang S, Pan C, Lin L, Tsai C, Wang C, et al.
Int J Radiat Oncol Biol Phys . 2023 Feb; 116(5):1135-1149. PMID: 36792014
Purpose: Ablative radiation therapy (RT) is an important strategy to eliminate primary tumor and can potentially induce the abscopal effect. Human serum albumin nanoparticle (NP) was used for controlled release...
3.
Chen J, Pan C, Lin L, Tsai C, Kuo C, Huang Y, et al.
Int J Radiat Biol . 2023 Jan; 99(8):1257-1266. PMID: 36598432
Purpose: To evaluate the therapeutic efficacy of cyclin-dependent kinase (CDK) inhibition in combination with ionizing radiation for lung cancer. Materials And Methods: Human lung adenocarcinoma (A549) and squamous cell carcinoma...
4.
Chen J, Pan C, Lin Y, Tsai C, Huang Y, Yang W, et al.
Strahlenther Onkol . 2021 Sep; 197(12):1131-1142. PMID: 34476531
Purpose: Development of a safe and effective systemic chemotherapeutic agent for concurrent administration with definitive thoracic radiotherapy remains a major goal of lung cancer management. The synergistic effect of PEGylated...
5.
Chen J, Pan C, Huang Y, Tsai C, Wang C, Lin Y, et al.
Cancer Immunol Immunother . 2020 Aug; 70(2):391-404. PMID: 32761424
C57BL/6 mice implanted in the flank with murine Lewis lung carcinoma cells were randomized into control, anti-angiogenic, anti-PD-L1, radiotherapy (RT), RT + anti-angiogenic, RT + anti-PD-L1, and RT + anti-PD-L1 ...
6.
Chen J, Wang M, Huang Y, Huang C, Pan C, Hsu C, et al.
J Xray Sci Technol . 2020 Jan; 28(1):111-124. PMID: 31904003
Background: Extended-field (EF) bone marrow-sparing (BMS) radiotherapy is attracting interest for cervical cancer patients with para-aortic lymphadenopathy. Objective: To compare dosimetric quality of volumetric-modulated arc therapy (VMAT) vs. helical tomotherapy...